Pharma Capital
CompanyCurrent (p)Value (£)
GlaxoSmithKline (GSK) 1615.00 90,048,023
AstraZeneca (AZN) 5152.00 81,249,461
Shire (SHP) 4156.50 78,556,686
GW Pharmaceuticals (GWP) 735.00 17,046,576
Hikma Pharmaceuticals (HIK) 1419.00 8,770,754
Abcam (ABC) 1007.00 7,066,038
Indivior (INDV) 316.40 5,721,895
BTG (BTG) 668.50 3,232,846
SkyePharma (SKP) 443.00 2,325,201
Dechra Pharmaceuticals (DPH) 1742.00 2,128,289
Clinigen Group (CLIN) 967.00 1,621,166
Vectura (VEC) 114.40 1,256,157
Genus (GNS) 1759.00 829,967
Oxford Biomedica (OXB) 8.46 235,316
Sarossa (SARS) 1.52 213,131
Motif Bio (MTFB) 29.00 75,253
Immupharma (IMM) 57.00 64,981
Alliance Pharma (APH) 53.25 36,507
Circassia Pharmaceuticals (CIR) 89.38 22,472
Premier Veterinary (PVG) 114.88 19,530
Horizon Discovery Group (HZD) 259.00 19,425
Animalcare Group (ANCR) 352.00 17,600
Quantum Pharma (QP.) 54.38 10,877
Source BioScience (SBS) 17.50 9,275
Tiziana Life Sciences (TILS) 163.50 5,723
Oxford BioDynamics (OBD) 161.75 4,125
Proteome Sciences (PRM) 4.60 2,254
Sinclair IS Pharma (SPH) 28.50 1,425
Abzena (ABZA) 51.50 1,288
Silence Therapeutics (SLN) 105.75 328

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.